The newly inaugurated MRI-guided proton therapy prototype in Dresden signals a paradigm shift in cancer treatment. This innovative system, merging a full-body MRI with real-time imaging and proton therapy, offers unprecedented accuracy. Pioneered by…
Continue Reading
The newly inaugurated MRI-guided proton therapy prototype in Dresden signals a paradigm shift in cancer treatment. This innovative system, merging a full-body MRI with real-time imaging and proton therapy, offers unprecedented accuracy. Pioneered by…
Continue Reading
NorthStar Medical Radioisotopes and Curadh MTR Inc. have forged an impactful collaboration aimed at advancing radiopharmaceuticals for solid tumor cancers. This alliance sees NorthStar’s expertise in manufacturing and distributing Ac-225, coupled with Curadh’s clinical…
Continue Reading
UR School of Nursing embraced tech-driven experiential learning, witnessing a 50% enrollment surge by mid-2023. Amidst healthcare challenges, this digital evolution bolstered workforce readiness, addressing nursing shortages and burnout. Immersive education, fueled by tablets…
Continue Reading
Penn Medicine’s iStar emerges as a game-changing AI tool, developed by Perelman School of Medicine experts. This revolutionary application, short for Inferring Super-Resolution Tissue Architecture, presents a paradigm shift in oncology diagnostics. iStar delves…
Continue Reading
Carrum Health’s collaboration with Florida Cancer Specialists & Research Institute facilitates a paradigm shift in breast cancer care accessibility. This union grants non-metastatic breast cancer patients associated with Carrum Health-linked employers a substantial two-year…
Continue Reading
Advancements in AI-driven healthcare and pharmaceuticals are reshaping the industry, evident through recent funding and collaborations. Peptris Technologies, backed by $1 million, expands AI drug discovery to rare diseases. Cipla boosts its stake in…
Continue Reading
AI’s synergy with radiology reshapes healthcare by enhancing diagnostics, streamlining workflows, and amplifying precision. Evolving from early skepticism, AI, especially deep learning and radiomics, redefines diagnostics. AI’s integration spans the patient journey, optimizing processes…
Continue Reading
SAN DIEGO – A common theme at the HIMSS AI in Healthcare Forum this past week was that artificial intelligence represents a new paradigm shift for how care is delivered (and paid for) and…
Continue Reading
Lance Hill, CEO of Within3
The cancer market for the pharma industry accounts for about a third of their product pipeline. With oncology drug sales set to top $390 billion by 2027, life science companies…
Continue Reading
